Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87,706Revenue $M51,016Net Margin (%)7.8Altman Z-Score1.9
Enterprise Value $M101,729EPS $4.8Operating Margin %9.6Piotroski F-Score4
P/E(ttm)21.4Beneish M-Score-2.6Pre-tax Margin (%)10.4Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %5.3Quick Ratio0.8Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %4.4Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow16.7y-y EBITDA Growth Rate %-0.2ROA % (ttm)5.1Higher Current Ratio y-yN
Dividend Yield %2.3PEG4.9ROE % (ttm)17.2Less Shares Outstanding y-yN
Payout Ratio %50.0Shares Outstanding M827ROIC % (ttm)8.7Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2015-12-31 Reduce$122.36 - $135.71
($128.61)
$ 106.06-18%Reduce -0.07%4,709,574
BAYRYKen Fisher 2015-09-30 Add0.03%$127.13 - $151.47
($139.59)
$ 106.06-24%Add 2.22%4,712,759
BAYRYKen Fisher 2015-06-30 Add0.59%$139.35 - $155
($147.22)
$ 106.06-28%Add 83.74%4,610,296
BAYRYKen Fisher 2015-03-31 Add$130.2 - $155.97
($144.95)
$ 106.06-27%Add 0.63%2,509,075
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 106.06-23%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 106.06-22%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 106.06-1%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 106.0637%Reduce -3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 106.0637%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 106.0677%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 106.0659%Add 24.27%46,440
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 106.06101%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 106.06101%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 106.06101%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BAYRY:

    News about BAYRY:

    Articles On GuruFocus.com
    Ken Fisher Cuts His Stake in Royal Bank, Buys Roche Holding Oct 12 2015 
    Ken Fisher's most weighted buys in Q2 2015 Jul 28 2015 
    UnitedHealth Group Reports Strong Second Quarter Earnings Results Jul 21 2015 
    Bayer AG Wins Approval On Existing Antibiotic For Plague Treatment May 12 2015 
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    DuPont Eyeing Acquisition To Leverage Its Market Spread Apr 24 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 

    More From Other Websites
    Bayer rejects EPA request to pull insecticide from U.S. market Feb 05 2016
    Merck beats 4Q profit forecast, misses Street view on sales Feb 03 2016
    Merck beats 4Q profit forecast, misses Street view on sales Feb 03 2016
    Jadelle Access Program -- Bayer halves the price of its contraceptive implant Jadelle® for women in... Jan 08 2016
    New edition of research, the Bayer scientific magazine, published -- Research for more quality of... Jan 07 2016
    How Did FEZ’s Pharmaceutical Industry Perform? Jan 06 2016
    Bayer AG downgraded by JP Morgan Jan 05 2016
    ASCO GU 2016 to Feature Latest Xofigo Research from Bayer Jan 05 2016
    Bayer closes on divestiture of Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for... Jan 05 2016
    Panasonic Healthcare Holdings Completes Acquisition of Leading Diabetes Care Business from Bayer AG Jan 05 2016
    [$$] Materials IPO Makes Strides Despite Headwinds Dec 29 2015
    Bayer Rose 2.1% as It Increased Investments in Cancer Drugs Dec 23 2015
    Moving Average Analysis of FEZ’s Pharmaceutical Industry Dec 23 2015
    A major gene-editing company just got $335 million to get its technology into people Dec 21 2015
    Bayer forms gene editing partnership with CRISPR Therapeutics Dec 21 2015
    Bayer and CRISPR Therapeutics AG join Forces to Discover, Develop and Commercialize Potential Cures... Dec 21 2015
    [$$] Bayer in Venture With Gene-Editing Startup Dec 21 2015
    Aspirin maker Bayer seeks to flex muscles in OTC sector Dec 16 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK